|
John M. Shoffner, M.D.
is board certified in Neurology, Biochemical Genetics, and in Molecular Genetics and
directs the Molecular Laboratory at Medical Neurogenetics. Dr. Shoffner is internationally recognized and called upon for
his work (clinical and research) with rare diseases (mitochondrial disease) and has authored over 70 research publications.
Keith Hyland, Ph.D.
is one of the leading experts in the world on neurotransmitter diseases and directs the
Medical Neurogenetics Neurochemistry Laboratory. He trained at Great Ormond Street Hospital, Institute of Child Health,
(London, UK) and directed the diagnostic and research activities of the Department of Neurochemistry, within the Institute of
Metabolic Disease, a part of the Baylor University Medical Center. He has twice been awarded the Society for the Study of Inborn
Errors of Metabolism yearly award and has extensive experience in the diagnosis and study of children with a wide variety of
inborn errors of metabolism that affect neurological function. He is a leading expert in the diagnosis and investigation of
inherited disorders affecting neurotransmitter and folate metabolism. Dr. Hyland has authored over 120 articles on rare diseases,
been the recipient of numerous competitively reviewed grants over his career, and received his Ph.D. at Brunel University
(United Kingdom) in 1980 in the field of biochemistry.
Lauren Collier Hyams, Ph.D.
is recognized for her research and publications in the fields of Molecular Genetics,
Immunology, and Microbiology. She received her Ph.D. in Microbiology from the University of Georgia and completed a postdoctoral
fellowship at Emory University School of Medicine. With her wide array of technical expertise, she leads our laboratory in the
areas of molecular biology, test development, research, and technology advancement.
Maureen E. Starnes, RN, CPNP
is certified as a Pediatric Nurse Practitioner. She received both her Bachelor's
and Master's Degrees in Nursing from Emory University. Maureen has a wide range of experience, both in the hospital setting where
she cared for critically ill infants at Emory-Crawford Long and Egleston Children’s Hospital, and in the outpatient setting at the
Emory-Children's Center. Her experience in child neurology at the Emory-Children's Center has focused her attention to the
challenges of the daily care of children facing chronic illness. She enters Medical Neurogenetics for the purpose of expanding
clinical practice, and improving access to the comprehensive care required by children with rare diseases. Maureen is uniquely
positioned to provide exceptional care with a focus on patient and family education.
|